Tag:

Vaccine

Ebola threat in DR Congo reaches “very high” level

The World Health Organization (WHO) has raised the public health risk of the ongoing Ebola outbreak in the Democratic Republic of Congo from "high" to "very high."

22 May 2026-19:22
EU boosts efforts on hantavirus vaccines

European Commissioner for Sustainable Transport and Tourism Apostolos Tzitzikostas stated on Thursday that the EU is stepping up efforts to create medical countermeasures against hantavirus infections.

21 May 2026-18:39
Australia announces $5.1M package to tackle diphtheria outbreak

21 May 2026-14:28
WHO experts meet to explore Ebola Bundibugyo vaccine options amid DR Congo outbreak

International health experts led by the World Health Organization are set to meet to discuss possible vaccine options to help contain a growing Ebola outbreak in eastern Democratic Republic of Congo. The meeting comes as health authorities respond to rising infections linked to the Bundibugyo strain of the virus.

19 May 2026-13:35
Australian researches develop low-cost heat-resistant malaria shot

13 May 2026-13:44
Moderna stock jumps after hantavirus vaccine update

Moderna shares rose 14.38% in Thursday morning trading following positive Phase 1 results for its mRNA hantavirus vaccine, which was well-tolerated and produced strong immune responses at all dose levels—an important milestone since no FDA-approved hantavirus vaccine currently exists.

08 May 2026-21:14
Covid vaccine 'an extraordinary feat' but trust must be rebuilt, inquiry finds

The development and rollout of the Covid vaccine was an extraordinary feat that saved an estimated 450,000 lives in England alone, but significant work remains to rebuild public trust.

16 Apr 2026-17:17
Australia launches world-first trial of cancer vaccines for kids

A world-first clinical trial will test personalised cancer vaccines for children with advanced or treatment-resistant brain tumours, supported by a A$2.578 million investment from the Australian Government.

03 Feb 2026-13:08
Brain training may boost vaccine response

Training the brain to boost positive expectations may help strengthen the immune system.

20 Jan 2026-10:00
Dynavax soars as Sanofi announces $2.2B acquisition

Sanofi (SNY) will acquire U.S. vaccine maker Dynavax Technologies (DVAX) for approximately $2.2 billion (1.9 billion euros), the French pharmaceutical company announced Wednesday.

24 Dec 2025-16:12

Prev Next